Laborie Medical Technologies to Acquire Clinical Innovations for $525 Million to Expand Global Maternal and Neonatal Care Market Presence

On December 20, 2019, VCBeat (WeChat ID: vcbeat) learned that Clinical Innovations, a medical device company dedicated to labor and delivery and neonatal intensive care, had signed a definitive agreement to be acquired by Laborie Medical Technologies for $525 million. The transaction is scheduled to close in early 2020.

Laborie Medical Technologies is a global leader in the development, manufacturing, and sales of innovative medical technologies and consumer products for the diagnosis and treatment of gastrointestinal and pelvic health conditions. The company was acquired by the private equity firm Patricia Industries in 2016. This acquisition will provide strong support for Clinical Innovations’ innovation in maternal and infant products and services, while enhancing Laborie Medical Technologies’ competitive advantage in the fields of labor and delivery and neonatal intensive care.

Clinical Innovations’ clinical medical device products hold leading market positions across multiple categories. These include: the Kiwi Vacuum Delivery System, designed to assist in operative vaginal deliveries; the Koala Intrauterine Pressure Catheter, a sensor-equipped catheter that monitors contraction strength during labor; ROM Plus, an amniotic membrane rupture test used to diagnose whether the fetal membranes have ruptured at the onset of labor; and babyLance, a heel lancet for obtaining blood samples to monitor infant health, which features an elliptical incision design to minimize surrounding tissue swelling.

Michael Frazzette, President and Chief Executive Officer of Laborie Medical Technologies, stated: “The acquisition of Clinical Innovations marks a significant step forward in our business development. We will continue to invest in market-leading technologies to deliver exceptional solutions for high-growth healthcare needs. Clinical Innovations provides Laborie Medical Technologies with a strong global presence in the specialized fields of labor and delivery and neonatal intensive care. Its diverse and differentiated portfolio of market-leading products truly brings transformative benefits to clinicians and their patients.”

Ken Reali, President and Chief Executive Officer of Clinical Innovations, stated, “This is a promising transaction that will expand our global reach. By joining forces with Laborie Medical Technologies, we will research and develop cutting-edge technologies and innovative medical devices, fulfilling our mission to improve the lives of mothers and their infants worldwide. This will have a positive impact on the global maternal and infant health market as well as related healthcare professionals.”

Clinical Innovations is one of the world’s largest healthcare manufacturers, dedicated to labor and delivery as well as neonatal intensive care. Since its establishment in 1993, Clinical Innovations has been expanding its global operations. The company boasts a management team with extensive experience in the medical device industry, committed to delivering high-quality services to its customers. Its devices are ISO 13485 certified, and the company has established strong partnerships with leading global medical distributors, enabling it to rapidly adapt to market trends and serve the global maternal and infant healthcare market.

(Compiled by Wang Jingna)